Unimed has acquired Elssi Maritime Services to enhance its maritime compliance solutions, integrating specialized drug and alcohol testing into its technology platform.
Target Information
Universal Maritime Solutions, commonly known as Unimed, is a prominent global provider specializing in medical and compliance solutions tailored for the maritime industry. Recently, the company announced its acquisition of Elssi Maritime Services, a leading provider based in Greece and Cyprus known for its drug and alcohol testing services within the maritime sector. Founded in 1993, Elssi has earned a reputation as a trusted partner for the international shipping community, offering not only drug and alcohol testing but also a wide range of services including drinking water analysis and benzene testing.
This strategic acquisition marks Unimed’s fourth under the ownership of ZCG Private Equity and follows the successful integration of Lagaay Medical Group earlier this year. By integrating Elssi's specialized testing services into its award-winning technology platform, Unimed aims to enhance the compliance resources available to its clients, creating a streamlined digital experience for health and safety management in maritime operations.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The maritime industry is a crucial component of global trade, facilitating the movement of goods across vast distances. Within this industry, compliance with health and safety regulations is paramount, particularly regarding drug and alcohol testing. As international regulat
Similar Deals
Universal Maritime Solutions → Elssi Maritime Services
2025
Gannet BioChem → Laysan Bio
2026
Universal Maritime Solutions (Unimed)
invested in
Elssi Maritime Services
in 2025
in a Other deal